e-learning
resources
Milan 2017
Sunday, 10.09.2017
Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Heat shock protein 90 inhibitors block pulmonary fibrosis and dysfunction in HCl-exposed mice.
J. Catravas (Norfolk, United States of America)
Source:
International Congress 2017 – Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis
Session:
Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis
Session type:
Thematic Poster
Number:
1033
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Catravas (Norfolk, United States of America). Heat shock protein 90 inhibitors block pulmonary fibrosis and dysfunction in HCl-exposed mice.. 1033
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Plethysmographic assessment of airway resistance
Introduction to airway resistance measurements
The use of NIV during rehabilitation
Related content which might interest you:
Aminoguanidine attenuates bleomycin-induced pulmonary fibrosis in rats through inhibition of heat shock protein 47 and TGF-β1 expression
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008
The potential role of intracellular heat shock protein 70 deficiency in aging and pulmonary fibrosis.
Source: International Congress 2017 – Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis
Year: 2017
The heat shock protein 90 inhibitor, 17-AAG, ameliorates pulmonary arteriolar and right ventricular hypertrophy in monocrotaline-induced pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary circulation II
Year: 2009
Post-treatment with the heat shock protein 90 (hsp90) inhibitor, AUY-922, reduces lung hsp90 tyrosine (Y) phosphorylation and pulmonary inflammation in LPS-induced acute lung injury (ALI) in mice
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Heat shock protein: a hot topic in idiopathic pulmonary fibrosis
Source: Eur Respir J , 49 (2) 1602152; DOI: 10.1183/13993003.02152-2016
Year: 2017
Heat shock proteins 70 and 90 expression in peripheral lung of COPD patients
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008
Increased expression of heat shock protein 70 in COPD
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
Vascular remodeling in the lung from mice treated with monocrotaline. The effect of protein C inhibitor transgenic expression
Source: Eur Respir J 2006; 28: Suppl. 50, 823s
Year: 2006
Enhanced lung fibrosis in protein C inhibitor transgenic mice
Source: Eur Respir J 2004; 24: Suppl. 48, 481s
Year: 2004
Protective effect of heat shock protein 90 (hsp90) inhibitors on endothelial barrier function
Source: Annual Congress 2007 - Acute and chronic lung injury and its repair: novel molecular insight
Year: 2007
Pirfenidone attenuates expression of HSP47 in murine bleomycin-induced pulmonary fibrosis
Source: Eur Respir J 2004; 24: 57-65
Year: 2004
Expression of heat shock protein 47 in chronic hypersensitivity pneumonitis
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015
Hypoxemic
vs.
normoxemic resuscitation from hemorrhagic shock attenuates pulmonary endothelial dysfunction
Source: Annual Congress 2007 - Pulmonary infections and inflammation
Year: 2007
Heat shock protein-90 toward theranostics: a breath of fresh air in idiopathic pulmonary fibrosis
Source: Eur Respir J, 51 (2) 1702612; 10.1183/13993003.02612-2017
Year: 2018
Nintedanib has acute pulmonary vasodilatory effects in transgenic Fra2 mice with spontaneous progressive pulmonary hypertension and lung fibrosis.
Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2019
The effect of dexamethasone on the pulmonary fibrosis of acute lung injury induced by lipopolysaccharide in rats
Source: Annual Congress 2007 - Respiratory pathophysiology
Year: 2007
Heat shock proteins (HSP)-10 and –40 increase in bronchial biopsies of patients with severe chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008
Hypoxemic resuscitation of hemorrhagic shock attenuates the pulmonary oxidative and inflammatory responses
Source: Eur Respir J 2005; 26: Suppl. 49, 222s
Year: 2005
Serum heat shock protein 47 levels in patients with drug induced lung diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Effect of NF-?B inhibitor IMD-1041 on BLM-induced pulmonary fibrosis in mice
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept